Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cassandre Gluszak
Observed name:
C. Gluszak
Institution:
Institut de Cancérologie de l'Ouest
Observed institution:
Institut de Cancérologie de l'Ouest
ORCID:
0000-0001-9162-1192
Observed ORCID:
0000-0001-9162-1192
OpenAlex ID:
A5044246522
Impact of Iron-Deficiency Management on Quality of Life in Patients with Cancer: A Prospective Cohort Study (CAMARA Study)
2022
·
Cassandre Gluszak
, Manon de Vries-Brilland
, et al.
·
The Oncologist
·
27
PDF
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX ‐bevacizumab failure for COlorectal cancer ( BEFLICO ): An AGEO multicenter study
2022
·
Cécile Torregrosa
, Simon Pernot
, et al.
·
International Journal of Cancer
·
12
Geriatric Assessment Implementation before Chemotherapy in MEtastatic Prostate Cancer, Results from the Real-Life Study GAMERS
2023
·
Cassandre Gluszak
, Loïc Campion
, et al.
·
Journal of Clinical Medicine
·
6
PDF
1822P Impact of iron-deficiency management on quality of life in cancer patients: A prospective cohort study (CAMARA study)
2020
·
C. Gluszak
, M. De Vries-Brilland
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
4
Citation count:
45
H-index:
3
I10-index:
2
Year
Topic
Type